tiprankstipranks
Trending News
More News >
N4 Pharma (GB:N4P)
LSE:N4P
UK Market

N4 Pharma (N4P) Financial Statements

Compare
6 Followers

N4 Pharma Financial Overview

N4 Pharma's market cap is currently £4.16M. The company's EPS TTM is p-0.001; its P/E ratio is -2.08; N4 Pharma is scheduled to report earnings on September 25, 2025, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue£ 7.28K£ 1.95K£ 0.00£ 0.00£ 0.00
Gross Profit£ 7.28K£ 1.95K£ 0.00£ 0.00£ 0.00
Operating Income£ -1.22M£ -1.43M£ -1.19M£ -1.84M£ -1.56M
EBITDA£ -1.22M£ -1.33M£ -1.19M£ -1.84M£ -1.56M
Net Income£ -1.06M£ -1.27M£ -1.03M£ -1.54M£ -1.30M
Balance Sheet
Cash & Short-Term Investments£ 625.97K£ 1.03M£ 1.92M£ 1.78M£ 3.56M
Total Assets£ 775.77K£ 1.28M£ 2.17M£ 2.34M£ 3.83M
Total Debt£ 0.00£ 0.00£ 0.00£ 0.00£ 0.00
Net Debt£ -625.97K£ -1.03M£ -1.92M£ -1.78M£ -3.56M
Total Liabilities£ 124.37K£ 81.73K£ 77.89K£ 212.73K£ 169.08K
Stockholders' Equity£ 647.65K£ 1.13M£ 2.09M£ 2.13M£ 3.66M
Cash Flow
Free Cash Flow£ -971.50K£ -1.21M£ -828.26K£ -1.77M£ -1.38M
Operating Cash Flow£ -971.50K£ -1.21M£ -828.26K£ -1.77M£ -1.38M
Investing Cash Flow£ 0.00£ 781.00£ 0.00£ 0.00£ 0.00
Financing Cash Flow£ 570.36K£ 315.90K£ 963.77K£ 677.00£ 3.97M
Currency in GBP

N4 Pharma Earnings and Revenue History

N4 Pharma Debt to Assets

N4 Pharma Cash Flow

N4 Pharma Forecast EPS vs Actual EPS